GSK Investigational Site
Děčín 405 01
0 studies enrolling now · 3 studies all time
What they study most
Influenza, Measles, Measles-Mumps-Rubella Vaccine, Mumps, Rubella
Studies at this site
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life — Completed
- Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children — Completed
- A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and Children — Completed